Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0000950170-25-113245

Options or other derivatives

  • Chief Financial Officer acquired 600,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Sendek Joel · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-09-04 Grant or award : show line 1 in the form Stock option (right to buy) +600,000 600,000 D
Loading xslF345X05/ownership.xml…